Print Friendly, PDF & Email

NCT/Study#

NCT04106167 /

FT-003

Long-Term, Non-Interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: